Why the study?
Many cardiovascular dysfunctions such as cardiac arrhythmias involve ion channel regulation, and natural products provide sources of compounds targeting these pathways.
Plant extracts and natural products modulate cardiac ion channels and contractility, highlighting their potential as sources for antiarrhythmic and cardiovascular therapies.
Answers are grounded in this paper and cite their sources.
Natural products' ion channel effects in cardiomyocytes remain hypothesis-generating; prospective trials needed before any clinical consideration.
Natural products (NPs) are endless sources of compounds for fighting against several pathologies. Many dysfunctions, including cardiovascular disorders, such as cardiac arrhythmias have their modes of action regulation of the concentration of electrolytes inside and outside the cell targeting ion channels. Here, we highlight plant extracts and secondary metabolites’ effects on the treatment of related cardiac pathologies on hERG, Nav, and Cav of cardiomyocytes. The natural product’s pharmacology of expressed receptors like alpha-adrenergic receptors causes an influx of Ca2+ ions through receptor-operated Ca2+ ion channels. We also examine the NPs associated with cardiac contractions such as myocardial contractility by reducing the L-type calcium current and decreasing the intracellular calcium transient, inhibiting the K+ induced contractions, decreasing amplitude of myocyte shortening and showed negative ionotropic and chronotropic effects due to decreasing cytosolic Ca2+. We examine whether the NPs block potassium channels, particular the hERG channel and regulatory effects on Nav1.7.
No takes yet. Share an insight, caveat, or question.
Seck et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: